Data / Form D filings / ViroMissile, Inc.
ViroMissile, Inc.: Form D filings
ViroMissile, Inc., a biotechnology company in La Jolla, CA, filed 4 Form D notices with the SEC between 2023 and 2025. The latest, on June 6, 2025, reports $500,000 sold of a $15 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 505 COAST BLVD SOUTH, SUITE 208, La Jolla, CA, 92037
- Phone
- (858) 886-7718
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1974798
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | Amendment | $15,000,000 | $500,000 | $14,500,000 | 5 | Mar 12, 2025 | sec.gov |
| Apr 22, 2025 | Amendment | $4,000,000 | $200,000 | $3,800,000 | 2 | Mar 12, 2025 | sec.gov |
| Mar 19, 2025 | New notice | $1,000,000 | $100,000 | $900,000 | 1 | Mar 12, 2025 | sec.gov |
| Apr 26, 2023 | New notice | $1,000,000 | $50,000 | $950,000 | 1 | Apr 18, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rolf G. Benirschke | Director | |
| Douglas G. Wall | Director | |
| Mark G. Bertagnolli | Executive Officer, Director | |
| Nanhai G. Chen | Executive Officer, Director | |
| Tianyu G. Zhou | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 2, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ViroMissile, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.